Furthermore, Lian et al. revealed that DANCR could enhance the acetyltransferase activity of lysine acetyltransferase 6 A (KAT6A) by binding to it, resulting in elevated KAT6A-mediated gene expression and promoting cell cycle progression in CRC. Here, KAT6A is linked to colorectal carcinoma.